Minimal clinical impact of embolization to new territory on outcomes in medium vessel occlusion strokes treated with mechanical thrombectomy: a retrospective multicenter study.

医学 栓塞 闭塞 多中心研究 回顾性队列研究 冲程(发动机) 外科 放射科 随机对照试验 机械工程 工程类
作者
Hamza Salim,Vivek Yedavalli,Dhairya A. Lakhani,Fathi Milhem,Basel Musmar,Nimer Adeeb,Tobias D. Faizy,Motaz Daraghma,Kareem El Naamani,Nils Henninger,Sri Hari Sundararajan,Anna Luisa Kühn,Jane Khalife,Sherief Ghozy,Luca Scarcia,Inayat Grewal,Leonard L.L. Yeo,Benjamin Yong‐Qiang Tan,Robert W. Regenhardt,Jeremy J. Heit
出处
期刊:PubMed
标识
DOI:10.1136/jnis-2024-022570
摘要

Mechanical thrombectomy (MT) is established as an effective treatment for large vessel occlusion strokes, but its efficacy and safety for medium vessel occlusions (MeVOs) remain less clear. This study examines the impact of periprocedural embolization to a new vascular territory (ENT) on clinical outcomes in patients with MeVO stroke treated with MT. A multicenter, retrospective analysis was conducted using the MAD-MT (Multicenter Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy) registry, including 2122 patients with MeVO stroke w-ho underwent MT between September 2017 and July 2023. ENT was defined as filling defects in previously unaffected territories, excluding embolization near the original occlusion, observed on final angiographic runs after retrieval of the primary thrombus. The associations between ENT, procedural variables, and 90-day clinical outcomes were evaluated, including functional independence (modified Rankin Scale (mRS) scores of 0-2), excellent outcomes (mRS 0-1), mortality, and hemorrhagic complications. ENT occurred in 2.9% (63/2122) of patients. Longer onset-to-arterial puncture time (adjusted OR 1.03; 95% CI 1.01 to 1.05; P=0.002) and a greater number of passes (adjusted OR 1.15; 95% CI 1.01 to 1.32; P=0.032) were associated with increased ENT risk, while excellent recanalization (thrombolysis in cerebral infarction (TICI) scale score 2c-3) was associated with reduced ENT risk (adjusted OR 0.41; 95% CI 0.23 to 0.72; P=0.002). ENT was not associated with poorer functional independence, mortality, or hemorrhagic complications. ENT during MT for MeVO stroke occurs infrequently and does not significantly affect the clinical outcomes. These findings suggest ENT risk should not deter clinicians from performing MT in patients with MeVO. Further prospective studies are needed to validate these results.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
shishi发布了新的文献求助10
1秒前
1秒前
1秒前
淡定依玉完成签到,获得积分10
3秒前
紫菜完成签到,获得积分10
3秒前
哈哈哈哈发布了新的文献求助10
3秒前
干净映天完成签到 ,获得积分10
5秒前
我爱学习发布了新的文献求助10
8秒前
10秒前
科研通AI2S应助jiang采纳,获得10
10秒前
11秒前
量子星尘发布了新的文献求助10
11秒前
12秒前
JackHYH完成签到,获得积分10
12秒前
胡慧婷完成签到 ,获得积分20
13秒前
安详靖巧完成签到,获得积分10
14秒前
shun完成签到,获得积分10
14秒前
小糖发布了新的文献求助10
14秒前
15秒前
小肖小肖还是小肖完成签到,获得积分10
15秒前
宅多点应助jack采纳,获得10
16秒前
17秒前
17秒前
打打应助我爱学习采纳,获得10
19秒前
Iridescent完成签到 ,获得积分10
21秒前
张明玉发布了新的文献求助10
22秒前
23秒前
小乌龟完成签到,获得积分10
23秒前
HaonanZhang应助银河系浮光采纳,获得10
23秒前
TTQQX完成签到,获得积分10
24秒前
打打应助zyy采纳,获得30
26秒前
奋斗的夜山完成签到 ,获得积分10
27秒前
27秒前
科研通AI6应助guoruiyong采纳,获得10
28秒前
开心的夏天完成签到,获得积分10
29秒前
wanci应助小富婆采纳,获得10
29秒前
橙子发布了新的文献求助10
29秒前
30秒前
30秒前
33秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1601
以液相層析串聯質譜法分析糖漿產品中活性雙羰基化合物 / 吳瑋元[撰] = Analysis of reactive dicarbonyl species in syrup products by LC-MS/MS / Wei-Yuan Wu 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 800
Biology of the Reptilia. Volume 21. Morphology I. The Skull and Appendicular Locomotor Apparatus of Lepidosauria 600
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 500
Pediatric Nutrition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5553225
求助须知:如何正确求助?哪些是违规求助? 4637764
关于积分的说明 14650974
捐赠科研通 4579638
什么是DOI,文献DOI怎么找? 2511776
邀请新用户注册赠送积分活动 1486737
关于科研通互助平台的介绍 1457665